Prior to founding Amalgam Rx, Mr. Sysko was the Co-Founder, CEO, and Chairman of WellDoc. The company helped pioneer the mobile health (“mHealth”) industry with one of the earliest FDA cleared, clinically-validated (through multiple randomized controlled trials), prescribed and reimbursed digital health products. The American Diabetes Association has listed WellDoc’s product, BlueStar, as the first and only Mobile Prescription Therapy. WellDoc has been recognized by Forbes as “One of America’s Most Promising Companies,” by the NASDAQ as “One of the Next Great Consumer Brands,” and by SmartCEO as a “Future 50 Fastest Growing Company.” Mr. Sysko has extensive background in helping to launch and develop start-up companies.
He was previously the senior vice president and director of marketing and business development for The Credo Group, one of the leading direct-to-consumer marketers of life and health insurance products on the Web. Prior to The Credo Group, he served in management positions within financial services companies such as Chase, Bank of America, and Conseco.
Mr. Bergstrom has been on the forefront of digital health for more than a decade. Recently serving as Partner and Head of Digital Therapy at Boston Consulting Group (BCG) where he helped the world’s leading life sciences companies design their digital health strategy. Prior to BCG, Chris was Chief Commercial Officer at WellDoc where he launched the world’s first digital therapy. He has a passion for championing the use of digital to decentralize healthcare and disrupt business models. As a recognized thought-leader, Chris is a frequent speaker and a former advisor to institutions such as ADA, FDA, & NIH. He also held executive roles at Roche, Becton Dickinson, P&G, and earned a BS from the IU Kelley School of Business and an MBA from Columbia University.
Prior to founding Amalgam Rx, Dr. Clough was the Co-Founder and Chief Medical Officer of WellDoc. Under Dr. Clough’s guidance, WellDoc developed the first clinically-validated, FDA-cleared, prescribed, and reimbursed software application for type 2 diabetes management. She is considered an SME in digital health behavioral and clinical frameworks and has extensive product development experience across the chronic disease domain. Prior to founding WellDoc, Dr. Clough, an internist, and endocrinologist by training was the founder and Medical Director at the Center for Weight Management and Wellness at the University of Maryland’s Medical Center (UMMC). While at UMMC, she was responsible for developing and managing the medical management protocols for the Center for Weight Management and Wellness, developing public service campaigns aimed at fighting obesity, providing clinical care for patients with general endocrinology issues and diabetes, and participating in the medical education of students, residents, and fellows.
Mr. Brooke brings a focused expertise in the medical device industry that combines more than 15 years of experience, inclusive of science and technology design, development, implementation, and testing; business strategy and operations; and legal and regulatory compliance. Jason has conducted scientific research (pre-clinical and clinical) and technology development in academic and industry environments as a biomedical engineer, worked within the FDA’s Center for Devices and Radiological Health (CDRH) as a program analyst, counseled clients as an attorney and consultant focused on the medical device and connected health space, and served as the chief executive officer and general counsel of a small medical device company.
Mr. Prasad is an experienced software architect and developer. Prior to founding Amalgam Rx, he was one of the initial technical hires at WellDoc where he was responsible for developing the BlueStar mobile and web platforms. Prior to WellDoc, Mr. Prasad was a Principal Investigator in Temasek Polytechnic’s Technology Research and Development unit, located in Singapore. During his tenure at Temasek Polytechnic, he led many software projects in collaboration with companies like Motorola, Philips, Siemens, and other local companies in Singapore.
Board of Directors
As the founder, CEO, and Chairman of two successful digital health companies, AmalgamRx and WellDoc, Mr. Sysko helped pioneer what is now known as the digital therapy and medicine industry. At WellDoc, they commercialized one of the earliest FDA cleared, clinically-validated (through multiple randomized controlled trials), prescribed, and reimbursed digital health products. The American Diabetes Association has listed WellDoc’s product, BlueStar, as the first and only Mobile Prescription Therapy. WellDoc has been recognized by Forbes as “One of America’s Most Promising Companies,” by the NASDAQ as “One of the Next Great Consumer Brands,” and by SmartCEO as a “Future 50 Fastest Growing Company.” Mr. Sysko has extensive background in helping to launch and develop start-up companies.
He was previously the senior vice president and director of marketing and business development for The Credo Group, one of the leading direct-to-consumer marketers of life and health insurance products on the Web. Prior to The Credo Group, he served in management positions within financial services companies such as Chase, Bank of America, and Conseco.
Sonny Vu is a senior executive with extensive experience at the intersection of health, technology, and consumer. He pioneered connected glucose meters, mobile medical applications, wearable activity trackers, digitized medical labs, and next-generation 3D printing all before their mass-market inflection points. Founder of Misfit, a wearables company acquired by Fossil Group (NASDAQ: FOSL) for $260 million, Vu was appointed Fossil’s president and chief technology officer, Connected Devices. Today, he serves as the founder of Alibaster (deep tech investment fund) and chief executive officer at AREVO (3D printed carbon fiber). Vu led two of Indegogo’s most successful campaigns and previously founded Elemental Machines (digitizing the lab), AgaMatrix (biosensors for diabetes), and FireSpout (natural language processing).
Jeff Courtney has over 25 years in leadership positions in operations, credit, and finance. He is the chief operating officer of CreditShop and was former managing director at JP Morgan Chase. In that role, Courtney oversaw operations infrastructure for the company's consumer and community banking, serving over 100 million customers. Previously, Courtney was head of operations for the company's credit card division, the world's largest issuer of Visa cards, and held leadership positions in finance, credit, and marketing at MBNA America.